Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Multiple Sclerosis and Related Disorders
|
February 18, 2022
Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments
H Bock, T Juretzek, R Handreka, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies
R Nau, H W Prange, M Kinzig, et al.
Biology of Reproduction
|
August 1, 1982
Normal development following in vitro fertilization in the cow
B G Brackett, D Bousquet, M L Boice, et al.
Acta Neurologica Scandinavica
|
November 7, 2006
Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis
A Dressel, A K Kolb, E Elitok, et al.
Clinical Laboratory
|
May 20, 2026
Impact of Lipoprotein (a) on the Quantification of LDL-Cholesterol
S Drobnik, A Koloi, H Scharnagl, et al.
Journal of Clinical and Experimental Neuropsychology
|
September 4, 2013
A brief Spanish-English equivalent version of the Boston Naming Test: a Project FRONTIER study
Danielle R Jahn, Cortney B Mauer, Chloe V Menon, et al.
The Journal of Experimental Medicine
|
December 19, 2001
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells
B A Small, S A Dressel, C W Lawrence, et al.
Journal of Neuroimmunology
|
November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b
J Brettschneider, D Ecker, A Bitsch, et al.
European Journal of Neurology
|
June 14, 2008
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients
A Millonig, A Dressel, D Bahner, et al.
Acta Neurologica Scandinavica
|
November 6, 2004
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis
A Bitsch, D Bahner, C Wachter, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Multiple Sclerosis and Related Disorders
|
February 18, 2022
Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments
H Bock, T Juretzek, R Handreka, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies
R Nau, H W Prange, M Kinzig, et al.
Biology of Reproduction
|
August 1, 1982
Normal development following in vitro fertilization in the cow
B G Brackett, D Bousquet, M L Boice, et al.
Acta Neurologica Scandinavica
|
November 7, 2006
Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis
A Dressel, A K Kolb, E Elitok, et al.
Clinical Laboratory
|
May 20, 2026
Impact of Lipoprotein (a) on the Quantification of LDL-Cholesterol
S Drobnik, A Koloi, H Scharnagl, et al.
Journal of Clinical and Experimental Neuropsychology
|
September 4, 2013
A brief Spanish-English equivalent version of the Boston Naming Test: a Project FRONTIER study
Danielle R Jahn, Cortney B Mauer, Chloe V Menon, et al.
The Journal of Experimental Medicine
|
December 19, 2001
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells
B A Small, S A Dressel, C W Lawrence, et al.
Journal of Neuroimmunology
|
November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b
J Brettschneider, D Ecker, A Bitsch, et al.
European Journal of Neurology
|
June 14, 2008
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients
A Millonig, A Dressel, D Bahner, et al.
Acta Neurologica Scandinavica
|
November 6, 2004
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis
A Bitsch, D Bahner, C Wachter, et al.
Page
of 4